ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 115 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q2 2020. The put-call ratio across all filers is 1.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,325,304 | +33.4% | 51,871 | +49.7% | 0.03% | +26.9% |
| Q2 2023 | $993,504 | +175.2% | 34,641 | +62.8% | 0.03% | +160.0% |
| Q4 2022 | $360,977 | +64.1% | 21,284 | +258.4% | 0.01% | -28.6% |
| Q4 2021 | $220,000 | -1.8% | 5,939 | +9.4% | 0.01% | -33.3% |
| Q1 2021 | $224,000 | +30.2% | 5,428 | -57.0% | 0.02% | +75.0% |
| Q1 2020 | $172,000 | – | 12,632 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Green Alpha Advisors, LLC | 8,394 | $264,663 | 0.19% |
| Global Wealth Strategies & Associates | 100 | $3,153 | 0.00% |